Austar Lifesciences Limited (6118.HK)

HKD 0.79

(0.0%)

Operating Income Summary of Austar Lifesciences Limited

Austar Lifesciences Limited's latest annual operating income in 2023 was -29.99 Million CNY , down -133.18% from previous year.
Austar Lifesciences Limited's latest quarterly operating income in 2024 Q2 was 17.25 Million CNY , down 0.0% from previous quarter.
Austar Lifesciences Limited reported an annual operating income of 90.39 Million CNY in 2022, down -22.72% from previous year.
Austar Lifesciences Limited reported an annual operating income of 116.96 Million CNY in 2021, up 343.38% from previous year.
Austar Lifesciences Limited reported a quarterly operating income of -29.99 Million CNY for 2023 FY, down -133.18% from previous quarter.
Austar Lifesciences Limited reported a quarterly operating income of -5.5 Million CNY for 2023 Q2, down -114.57% from previous quarter.

Annual Operating Income Chart of Austar Lifesciences Limited (2023 - 2013)

Historical Annual Operating Income of Austar Lifesciences Limited (2023 - 2013)

Year	Operating Income	Operating Income Growth
2023	-29.99 Million CNY	-133.18%
2022	90.39 Million CNY	-22.72%
2021	116.96 Million CNY	343.38%
2020	26.38 Million CNY	895.13%
2019	2.65 Million CNY	144.07%
2018	-6.01 Million CNY	91.17%
2017	-68.12 Million CNY	-231.76%
2016	-20.53 Million CNY	-552.87%
2015	4.53 Million CNY	-94.64%
2014	84.65 Million CNY	17.76%
2013	71.88 Million CNY	0.0%

Year	Operating Income	Operating Income Growth
2024 Q2	17.25 Million CNY	0.0%
2023 FY	-29.99 Million CNY	-133.18%
2023 Q2	-5.5 Million CNY	-114.57%
2022 Q2	52.58 Million CNY	-22.36%
2022 Q4	37.81 Million CNY	-28.09%
2022 FY	90.39 Million CNY	-22.72%
2021 Q2	49.24 Million CNY	266.49%
2021 FY	116.96 Million CNY	343.38%
2021 Q4	67.72 Million CNY	37.54%
2020 Q4	13.43 Million CNY	3.79%
2020 Q2	12.94 Million CNY	623.59%
2020 FY	26.38 Million CNY	895.13%
2019 Q2	862 Thousand CNY	157.31%
2019 FY	2.65 Million CNY	144.07%
2019 Q4	1.78 Million CNY	107.54%
2018 Q2	-6.35 Million CNY	81.27%
2018 Q4	335 Thousand CNY	105.28%
2018 FY	-6.01 Million CNY	91.17%
2017 FY	-68.12 Million CNY	-231.76%
2017 Q4	-33.9 Million CNY	0.92%
2017 Q2	-34.21 Million CNY	-399.46%
2016 FY	-20.53 Million CNY	-552.87%
2016 Q2	-13.68 Million CNY	-83.28%
2016 Q4	-6.85 Million CNY	49.93%
2015 FY	4.53 Million CNY	-94.64%
2015 Q4	-7.46 Million CNY	-162.21%
2015 Q2	11.99 Million CNY	-72.58%
2014 FY	84.65 Million CNY	17.76%
2014 Q4	43.75 Million CNY	6.97%
2014 Q2	40.9 Million CNY	57.65%
2013 Q2	45.94 Million CNY	135.61%
2013 Q4	25.94 Million CNY	-43.53%
2013 FY	71.88 Million CNY	0.0%
2012 Q4	19.5 Million CNY	0.0%

Peer Operating Income Comparison of Austar Lifesciences Limited

Name	Operating Income	Operating Income Difference
Vincent Medical Holdings Limited	65.78 Million HKD	145.597%